Home - Products - MAPK/ERK Signaling - p38 MAPK - TAK1-IN-3

TAK1-IN-3

CAS No. 494772-87-1

TAK1-IN-3( —— )

Catalog No. M35215 CAS No. 494772-87-1

TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	70	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

TAK1-IN-3
Note

Research use only, not for human use.
Brief Description

TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.
Description

TAK1-IN-3 is a potent ATP-competitive TAK1 inhibitor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

p38 MAPK
Recptor

MAPK
Research Area

——
Indication

——

Chemical Information

CAS Number

494772-87-1
Formula Weight

317.41
Molecular Formula

C16H19N3O2S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (315.05 mM; Ultrasonic )
SMILES

O=C(N)C=1SC(=CC1N)C=2C=CC(=CC2)CN3CCOCC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BI-2865

BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 binds to WT, G12C, G12D, G12V and G13D mutant KRAS with KDs of 6.9, 4.5, 32, 26, 4.3 nM respectively.
FPH2

FPH2 (BRD-9424) is a small molecule promoting differentiation of iPS-derived hepatocytes.
p38-α MAPK-IN-1

p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.

Sign In Join Free